mRNA therapeutics and Vaccines market Research Report by 2022, Forecast till 2035
Characterized by a rapidly growing pipeline of products, the mRNA therapeutics and vaccines segment is anticipated to revolutionize the biopharmaceutical industry
Roots Analysis is pleased to announce the publication of its recent study, titled, “mRNA Therapeutics and mRNA Vaccines Market, 2022-2035”. The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade.
It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
A detailed overview of the overall market landscape of mRNA therapeutics and vaccines, based on several relevant parameters.
A detailed overview of the current market of players engaged in the development of mRNA therapeutics and vaccines.
An in-depth company competitiveness analysis of mRNA therapeutics and vaccines developers based on their portfolio strength (in terms of year of establishment and company size), pipeline strength (in terms of its pipeline maturity and drug administration route) and number of therapeutic areas targeted.
Detailed profiles of marketed and late stage (phase III) mRNA therapeutics and mRNA vaccines.
A review of the various mRNA-focused initiatives undertaken by big pharma players (shortlisted on the basis of the revenues generated in 2021).
An analysis of start-ups (established between 2016-2022) engaged in this domain, based on several relevant parameters.
An analysis of completed, ongoing and planned clinical studies of mRNA therapeutics and vaccines, based on several relevant parameters.
An analysis of recent collaborations and partnerships within the mRNA therapeutics and vaccines industry.
A detailed analysis of various investments made by players engaged in this domain, during the period 2013-2022.
An in-depth analysis of the various patents that have been filed / granted related to mRNA therapeutics and vaccines domain, since 2016.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Routes of Administration
Intradermal
Intravenous
Intranasal
Others
Therapeutic Area
Infectious Diseases
Oncological Disorders
Other Disorders
Key Geographical Regions
North America
Europe
Asia-Pacific
Latin America
Middle East and North Africa
Key companies covered in the report
Arcturus Therapeutics
BioNTech and Pfizer
CureVac
Gennova
Moderna
Walvax
To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/mrna-therape
You may also be interested in the following titles:
Gene Switch Market
Digital Biomanufacturing Market
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#mrna therapeutics and Vaccines Market #mrnatherapeuticsandvaccinesmarketgrowth #mrnavaccines #mrnabasedvaccines #mrnatherapeutics
